L-Isoleucine Powder for BCAA Blends and Muscle Recovery Formulas

L-Isoleucine Overview

L-Isoleucine is an essential branched-chain amino acid, which means the human body cannot synthesize it and it must be obtained from diet or supplementation, making it a standard component of BCAA and muscle-recovery products. It is identified by CAS number 73-32-5, molecular formula C6H13NO2 and molecular weight 131.17 g/mol. As one of the three BCAAs, L-isoleucine participates in muscle protein metabolism, glucose uptake during exercise and energy production in skeletal muscle.

For the dietary supplement industry, L-isoleucine is used in sports nutrition, muscle recovery, endurance and strength products, almost always in balanced BCAA blends with L-leucine and L-valine. Purecium supplies L-isoleucine as a white crystalline powder standardized to 99.0% minimum assay, produced by microbial fermentation and sold exclusively as a B2B raw material for distributors, contract manufacturers, private-label producers and finished supplement brands.

Source & Ingredient Identity

Purecium L-Isoleucine is manufactured by microbial fermentation, the dominant commercial route for food-grade isoleucine, in which selected microbial strains convert non-GMO plant-based sugars into the L-enantiomer under controlled fermentation conditions, followed by purification by crystallization. The fermentation process inherently produces the natural L-enantiomer, the only form used in human nutrition.

The product is standardized to 99.0% minimum assay and conforms to USP-NF and European Pharmacopoeia monographs as applicable, produced in China and non-irradiated, with no allergens, no gluten and no GMO material. For B2B buyers, the critical purchasing checks are the assay on the Certificate of Analysis, specific optical rotation confirming the L-enantiomer, and the related-impurity profile, which is the key quality parameter for amino acids.

Key Characteristics of L-Isoleucine

1. Essential BCAA for muscle metabolism. L-Isoleucine is one of the three branched-chain amino acids that are oxidized in skeletal muscle rather than the liver; along with L-leucine and L-valine it supports muscle protein turnover, recovery and the maintenance of lean mass, a role reflected in the sports-nutrition guidance of regulatory and nutrition authorities.

2. Glucose and energy metabolism support. Unlike the other BCAAs, L-isoleucine has a distinct role in glucose uptake into muscle cells and energy metabolism during exercise, which supports endurance performance and glycogen sparing; published clinical studies suggest benefits of BCAA supplementation for exercise recovery and muscle soreness.

3. Enantiomerically defined and well regulated. L-Isoleucine is recognized as GRAS by the FDA and covered by USP-NF and European Pharmacopoeia monographs, with specific optical rotation confirming the L-enantiomer. Its crystalline form, neutral taste and excellent flow make it easy to blend in BCAA powders, capsules and tablets.

L-Isoleucine Manufacturing

The manufacturing process follows a fermentation route: selected microbial strains convert non-GMO plant-based sugars into L-isoleucine under controlled fermentation conditions, after which the broth is filtered, purified by ion exchange and crystallization, and dried to a white crystalline powder. Every production stage is process-controlled, and each finished lot is verified before release.

Each batch is tested by the methods of the current USP-NF or European Pharmacopoeia monograph for isoleucine, including identification by infrared spectroscopy, assay (99.0% minimum on a dried basis), specific optical rotation confirming the L-enantiomer, related substances and impurities by HPLC, heavy metals, residual solvents and microbial limits, all reported on the batch Certificate of Analysis. Each lot is traceable from fermentation culture to finished drum.

Applications of L-Isoleucine

Sports nutrition and muscle recovery is the primary application of L-isoleucine. Mechanistically, the BCAAs are oxidized in skeletal muscle, where they contribute to energy production during exercise and provide substrate for muscle protein metabolism; published clinical studies suggest that BCAA supplementation supports recovery from exercise and reduces muscle soreness after intense training. Typical servings range from 1 g to 2.5 g of L-isoleucine within a balanced BCAA blend.

Endurance, strength and clinical nutrition form the second cluster. L-isoleucine is used in endurance formulas for its glucose-uptake and energy-substrate role, in strength and recovery products alongside L-leucine and L-valine, and in clinical and medical nutrition where branched-chain amino acids support nitrogen balance and muscle maintenance. The FDA recognizes L-isoleucine as GRAS for food use, and EFSA has assessed amino acids including isoleucine for use in food supplements; finished-product claims should always follow the regulations of the destination market.

L-Isoleucine is compatible with capsules, tablets, sachets and powder blends, and it is the standard second component of 2:1:1 BCAA blends. The white crystalline powder has a neutral taste and good flow, and it is commonly paired with L-leucine, L-valine, electrolytes and citrulline or beta-alanine in sports formulas. Formulators should keep isoleucine in sealed containers to avoid moisture uptake during blending and storage.

Manufacturing & Quality Control

Purecium L-Isoleucine is produced in facilities operating under ISO 9001 and FSSC 22000 certified quality systems, with Kosher and Halal certification available. Analytical methods follow the current USP-NF and European Pharmacopoeia monographs for isoleucine, and each batch is released with a verified assay of 99.0% minimum on a dried basis.

Each commercial lot is fully traceable from fermentation culture to finished drum. Alongside the CoA, Purecium provides the specification sheet, SDS, allergen and gluten statements, non-GMO declarations and stability data on request, giving buyers the documentation needed for raw-material approval and finished-product registration.

L-Isoleucine for B2B Supplement Manufacturing

Purecium supplies L-Isoleucine exclusively as a B2B raw material for distributors, contract manufacturers, private-label producers and finished supplement brands. The minimum order quantity is 25 kg; the powder is packed in 25 kg drums with food-grade aluminum-foil inner bags, and samples and full documentation are available before commitment.

For North American customers, inventory is staged at Purecium's US warehouse, enabling pickup or delivery within approximately two days. Global delivery covers Hong Kong, mainland China, the EU and other regions, with export documentation prepared for every shipment. Purecium also supports custom mesh sizing and provides technical and regulatory communication to move L-isoleucine from ingredient selection to commercial formulation.

Reviewed by the Chief Quality Assurance / Regulatory Affairs Specialist at Purecium for technical accuracy and regulatory alignment.

How does bulk L-isoleucine compare with L-leucine, L-valine and BCAA blends in specification, dosing, handling and regulatory terms?
L-Isoleucine (CAS 73-32-5) is one of the three branched-chain amino acids. In bulk form it is supplied as a white crystalline powder, typically with an assay specification of 98.5-101.5% on a dried basis, conforming to the USP/EP monographs where a pharmacopoeial grade is required. L-leucine (CAS 61-90-5) and L-valine (CAS 72-18-4) share the same chemical class, the same stereochemistry and broadly similar specification ranges, so the three are frequently purchased against a common internal specification. A BCAA blend is not a single substance but a physical mixture, usually at a 2:1:1 ratio of leucine to isoleucine to valine, and its specification is therefore defined by the blend ratio, homogeneity and the individual component assays rather than by a single monograph. Dosing differs by intended use. In sports nutrition, leucine is the most studied for mTOR pathway signalling and is often dosed at 2-3 g per serving, while isoleucine and valine are typically used at 1-2 g each, consistent with the 2:1:1 blend logic. In clinical nutrition and amino acid infusion formulations, isoleucine is used at gram-level quantities as part of a balanced amino acid profile. Formulators should note that isoleucine is the most hydrophobic of the three and has the lowest aqueous solubility, which affects beverage and ready-to-drink applications. Handling is comparable across the three: all are hygroscopic to a limited degree, should be stored in sealed containers below 25 degrees Celsius, protected from moisture and direct light, and are generally stable for 24-36 months under those conditions. Isoleucine and valine are more prone to bitter taste perception than leucine, which matters in oral dosage forms. Regulatory status is similar: all three are permitted food ingredients in the EU and US, and are listed in the relevant pharmacopoeias. A BCAA blend carries the regulatory status of its components, but the blend itself requires its own specification and, where applicable, labelling of the ratio. Documentation for bulk supply typically includes a certificate of analysis, specification sheet, safety data sheet, allergen statement, non-GMO statement and, where required, halal or kosher certificates. For a blend, an additional homogeneity and ratio verification method should be requested.

Comparison in table form.
The table below sets out the parameters that determine how each material is specified, dosed and documented in a finished formulation.